Cargando…
A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
BACKGROUND: Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition. CASE PRESENTATION: We report the case of a 10-y...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448353/ https://www.ncbi.nlm.nih.gov/pubmed/32847563 http://dx.doi.org/10.1186/s13052-020-00888-3 |
_version_ | 1783574482933252096 |
---|---|
author | Tornese, Gianluca Patti, Giuseppa Pellegrin, Maria Chiara Costa, Paola Faletra, Flavio Faleschini, Elena Barbi, Egidio |
author_facet | Tornese, Gianluca Patti, Giuseppa Pellegrin, Maria Chiara Costa, Paola Faletra, Flavio Faleschini, Elena Barbi, Egidio |
author_sort | Tornese, Gianluca |
collection | PubMed |
description | BACKGROUND: Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition. CASE PRESENTATION: We report the case of a 10-year-old Caucasian boy referred for short stature (height − 2.56 SDS) and delayed growth (growth velocity − 4.33 SDS) who was diagnosed with GHD and started treatment with recombinant human growth hormone (rhGH). Because of his history of seizures with infantile onset, deceleration of head growth with microcephaly, ataxia, and moderate intellectual disability, a lumbar puncture was performed, which revealed a low CSF glucose concentration with a very low CSF-to-blood glucose ratio (< 0.4), and genetic tests detected a SLC2A1 gene exon 1 deletion confirming a diagnosis of GLUT1DS. Ketogenic diet was started. After 5.5 years of rhGH treatment his height was normalized (− 1.15 SDS). No side effects were reported during treatment, particularly on glycemic metabolism. CONCLUSIONS: This is the first case of GHD in a Caucasian boy with GLUT1DS diagnosed before starting ketogenic diet, with a good response to rhGH treatment and absence of side effects. We speculate that GHD may represent a poorly recognized clinical feature of GLUT1DS rather than a complication due to ketogenic diet. Under-diagnosis may derive from the fact that growth failure is usually ascribed to ketogenic diet and therefore not further investigated. Pediatric neurologists need to be alerted to the possible presence of GHD in patients with GLUT1DS with slow growth, while pediatric endocrinologist need to refer GHD patients with additional features (motor and cognitive developmental delay, seizures with infantile onset, deceleration of head growth with acquired microcephaly, movement disorder with ataxia, dystonia, and spasticity) that may suggest GLUT1DS. |
format | Online Article Text |
id | pubmed-7448353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74483532020-08-27 A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet Tornese, Gianluca Patti, Giuseppa Pellegrin, Maria Chiara Costa, Paola Faletra, Flavio Faleschini, Elena Barbi, Egidio Ital J Pediatr Case Report BACKGROUND: Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition. CASE PRESENTATION: We report the case of a 10-year-old Caucasian boy referred for short stature (height − 2.56 SDS) and delayed growth (growth velocity − 4.33 SDS) who was diagnosed with GHD and started treatment with recombinant human growth hormone (rhGH). Because of his history of seizures with infantile onset, deceleration of head growth with microcephaly, ataxia, and moderate intellectual disability, a lumbar puncture was performed, which revealed a low CSF glucose concentration with a very low CSF-to-blood glucose ratio (< 0.4), and genetic tests detected a SLC2A1 gene exon 1 deletion confirming a diagnosis of GLUT1DS. Ketogenic diet was started. After 5.5 years of rhGH treatment his height was normalized (− 1.15 SDS). No side effects were reported during treatment, particularly on glycemic metabolism. CONCLUSIONS: This is the first case of GHD in a Caucasian boy with GLUT1DS diagnosed before starting ketogenic diet, with a good response to rhGH treatment and absence of side effects. We speculate that GHD may represent a poorly recognized clinical feature of GLUT1DS rather than a complication due to ketogenic diet. Under-diagnosis may derive from the fact that growth failure is usually ascribed to ketogenic diet and therefore not further investigated. Pediatric neurologists need to be alerted to the possible presence of GHD in patients with GLUT1DS with slow growth, while pediatric endocrinologist need to refer GHD patients with additional features (motor and cognitive developmental delay, seizures with infantile onset, deceleration of head growth with acquired microcephaly, movement disorder with ataxia, dystonia, and spasticity) that may suggest GLUT1DS. BioMed Central 2020-08-26 /pmc/articles/PMC7448353/ /pubmed/32847563 http://dx.doi.org/10.1186/s13052-020-00888-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Tornese, Gianluca Patti, Giuseppa Pellegrin, Maria Chiara Costa, Paola Faletra, Flavio Faleschini, Elena Barbi, Egidio A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
title | A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
title_full | A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
title_fullStr | A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
title_full_unstemmed | A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
title_short | A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
title_sort | case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448353/ https://www.ncbi.nlm.nih.gov/pubmed/32847563 http://dx.doi.org/10.1186/s13052-020-00888-3 |
work_keys_str_mv | AT tornesegianluca acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT pattigiuseppa acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT pellegrinmariachiara acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT costapaola acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT faletraflavio acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT faleschinielena acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT barbiegidio acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT tornesegianluca casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT pattigiuseppa casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT pellegrinmariachiara casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT costapaola casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT faletraflavio casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT faleschinielena casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet AT barbiegidio casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet |